Piedmont Investment Advisors’s CareDx CDNA Stock Holding History

Piedmont Investment Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-561	Closed	-$7K	–	1245
2018 Q2	$7K	Buy	+561	New	+$6.43K	﹤0.01%	1961

Other funds holding CDNA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Piedmont Investment Advisors's CDNA Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of CareDx (CDNA) in Q3 2018, closing a stake of 561 shares — an estimated $7K sold.

Piedmont Investment Advisors first reported a position in CDNA in Q2 2018 and held it in 1 quarter. The position peaked at $7K in Q2 2018. 139 funds tracked by Wall St. Rank hold CDNA as of Q3 2018.

Piedmont Investment Advisors reported no remaining CareDx position as of Q3 2018 after selling out during the quarter.
Piedmont Investment Advisors sold 561 CareDx shares in Q3 2018, an estimated $7K.
Piedmont Investment Advisors first reported a position in CareDx in Q2 2018 and held it in 1 quarter.
Piedmont Investment Advisors's CareDx position peaked at $7K in Q2 2018.
139 funds tracked by Wall St. Rank held CareDx as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.